4.8 Editorial Material

The tumor as organizer model

Journal

SCIENCE
Volume 363, Issue 6431, Pages 1038-1039

Publisher

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/science.aau9861

Keywords

-

Funding

  1. NIH [CA169123, DK104196, DK083355]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Tumor Cell-Intrinsic USP22 Suppresses Antitumor Immunity in Pancreatic Cancer

Jinyang Li, Salina Yuan, Robert J. Norgard, Fangxue Yan, Taiji Yamazoe, Andres Blanco, Ben Z. Stanger

CANCER IMMUNOLOGY RESEARCH (2020)

Article Biochemistry & Molecular Biology

Senescence-Induced Vascular Remodeling Creates Therapeutic Vulnerabilities in Pancreas Cancer

Marcus Ruscetti, John P. Morris, Riccardo Mezzadra, James Russell, Josef Leibold, Paul B. Romesser, Janelle Simon, Amanda Kulick, Yu-jui Ho, Myles Fennell, Jinyang Li, Robert J. Norgard, John E. Wilkinson, Direna Alonso-Curbelo, Ramya Sridharan, Daniel A. Heller, Elisa de Stanchina, Ben Z. Stanger, Charles J. Sherr, Scott W. Lowe

Article Oncology

Global Regulation of the Histone Mark H3K36me2 Underlies Epithelial Plasticity and Metastatic Progression

Salina Yuan, Ramakrishnan Natesan, Francisco J. Sanchez-Rivera, Jinyang Li, Natarajan Bhanu, Taiji Yamazoe, Jeffrey H. Lin, Allyson J. Merrell, Yogev Sela, Stacy K. Thomas, Yanqing Jiang, Jacqueline B. Plesset, Emma M. Miller, Junwei Shi, Benjamin A. Garcia, Scott W. Lowe, Irfan A. Asangani, Ben Z. Stanger

CANCER DISCOVERY (2020)

Editorial Material Immunology

Cell Cycle Regulation Meets Tumor Immunosuppression

Jinyang Li, Ben Z. Stanger

TRENDS IN IMMUNOLOGY (2020)

Article Gastroenterology & Hepatology

Pharmacologic Activation of the G Protein-Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma

Christopher A. Natale, Jinyang Li, Jason R. Pitarresi, Robert J. Norgard, Tzvete Dentchev, Brian C. Capell, John T. Seykora, Ben Z. Stanger, Todd W. Ridky

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Gastroenterology & Hepatology

Dynamic Transcriptional and Epigenetic Changes Drive Cellular Plasticity in the Liver

Allyson J. Merrell, Tao Peng, Jinyang Li, Kathryn Sun, Bin Li, Takeshi Katsuda, Markus Grompe, Kai Tan, Ben Z. Stanger

Summary: Hepatocytes undergo extensive chromatin and transcriptional changes during biliary reprogramming, resulting in altered gene expression profiles including robust induction of biliary genes and weaker repression of hepatocyte genes. Single-cell analysis revealed that Smad4 mutation can significantly increase reprogramming.

HEPATOLOGY (2021)

Article Medicine, Research & Experimental

The vascular landscape of human cancer

Benjamin M. Kahn, Alfredo Lucas, Rohan G. Alur, Maximillian D. Wengyn, Gregory W. Schwartz, Jinyang Li, Kathryn Sun, H. Carlo Maurer, Kenneth P. Olive, Robert B. Faryabi, Ben Z. Stanger

Summary: Through studying the tumor vascular environment, the use of the endothelial index (EI) and vascular microenvironment signatures (VMS) can better assess tumor vascular density, which is associated with prognosis in certain cancer types. These findings suggest that these metrics may enable more precise deployment of antiangiogenesis therapy.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Oncology

PTHrP Drives Pancreatic Cancer Growth and Metastasis and Reveals a New Therapeutic Vulnerability

Jason R. Pitarresi, Robert J. Norgard, Anna M. Chiarella, Kensuke Suzuki, Basil Bakir, Varun Sahu, Jinyang Li, Jun Zhao, Benoit Marchand, Maximilian D. Wengyn, Antony Hsieh, Il-Kyu Kim, Amy Zhang, Karine Sellin, Vivian Lee, Shigetsugu Takano, Yoji Miyahara, Masayuki Ohtsuka, Anirban Maitra, Faiyaz Notta, Richard Kremer, Ben Z. Stanger, Anil K. Rustgi

Summary: The amplification of PTHrP in pancreatic cancer is related to tumor growth and metastasis, and its loss can significantly reduce tumor burden, eliminate metastasis, and enhance overall survival. Targeting PTHrP activity may be a novel therapeutic approach for treating pancreatic cancer.

CANCER DISCOVERY (2021)

Article Biology

Dissecting phenotypic transitions in metastatic disease via photoconversion-based isolation

Yogev Sela, Jinyang Li, Paola Kuri, Allyson J. Merrell, Ning Li, Chris Lengner, Pantelis Rompolas, Ben Z. Stanger

Summary: The study introduced a new technique called PIC-IT, which allows efficient isolation of cell clusters of any size, including single-metastatic cells. In a murine pancreatic cancer model, transcriptional profiling of spontaneously arising microcolonies revealed phenotypic heterogeneity, reduced propensity to proliferate, and enrichment for an inflammatory-response phenotype associated with NF-kappa B/AP-1 signaling.

ELIFE (2021)

Article Biochemistry & Molecular Biology

Calcium signaling induces a partial EMT

Robert J. Norgard, Jason R. Pitarresi, Ravikanth Maddipati, Nicole M. Aiello-Couzo, David Balli, Jinyang Li, Taiji Yamazoe, Maximilian D. Wengyn, Ian D. Millstein, Ian W. Folkert, Derick N. Rosario-Berrios, Il-Kyu Kim, Jared B. Bassett, Riley Payne, Corbett T. Berry, Xiaodong Feng, Kathryn Sun, Michele Cioffi, Priyanka Chakraborty, Mohit Kumar Jolly, J. Silvio Gutkind, David Lyden, Bruce D. Freedman, J. Kevin Foskett, Anil K. Rustgi, Ben Z. Stanger

Summary: Epithelial-mesenchymal transition (EMT) is a form of cellular plasticity that gives tumor cells invasiveness and alters their sensitivity to drugs, posing a challenge to cancer therapy. Carcinoma cells in a partial EMT state have higher metastatic capacity than those in extreme states. Prolonged calcium signaling induces a partial EMT characterized by the internalization of membrane-associated E-cadherin and increased migration and invasion abilities.

EMBO REPORTS (2021)

Article Oncology

Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer

Yogev Sela, Jinyang Li, Shivahamy Maheswaran, Robert Norgard, Salina Yuan, Maimon Hubbi, Miriam Doepner, Jimmy P. Xu, Elaine S. Ho, Clementina Mesaros, Colin Sheehan, Grace Croley, Alexander Muir, Ian A. Blair, Ophir Shalem, Chi V. Dang, Ben Z. Stanger

Summary: Solid tumors have heterogeneous metabolic microenvironments, with some regions being rich in oxygen and nutrients, while others are scarce. Cancer cells in the arid regions exhibit a slow-cycling state and are resistant to chemotherapy. Bcl-xL plays a central role in the adaptation of cancer cells to nutrient and oxygen deprivation. Combining traditional cancer therapies that target rapidly cycling cells with those that target quiescent, chemoresistant cells associated with nutrient and oxygen deprivation could improve treatment efficacy and patient survival.

CANCER RESEARCH (2022)

Article Oncology

Protection of Regulatory T Cells from Fragility and Inactivation in the Tumor Microenvironment

Hongru Zhang, Vivek S. Tomar, Jinyang Li, Raghavendra Basavaraja, Fangxue Yan, Jun Gui, Noreen McBrearty, Tara Lee Costich, Daniel P. Beiting, M. Andres Blanco, Jose R. Conejo-Garcia, Gurpanna Saggu, Allison Berger, Yulia Nefedova, Dmitry Gabrilovich, Serge Y. Fuchs

Summary: This study reveals a mechanism by which intratumoral regulatory T (Treg) cells retain their immunosuppressive activities by downregulating the IFNAR1 chain of the type I interferon (IFN1) receptor. The downregulation of IFNAR1 mediated by p38α kinase protects Treg cells from fragility and maintains NRP1 levels, which are crucial for immune suppression. Inhibition of p38α or stabilization of IFNAR1 induces fragility in Treg cells and inhibits their immune suppressive and protumorigenic functions. These findings provide insights into the mechanisms of immune regulation in the tumor microenvironment and suggest strategies for enhancing the efficacy of immunotherapies by inducing Treg cell fragility.

CANCER IMMUNOLOGY RESEARCH (2022)

Article Oncology

KAT6A and ENL Form an Epigenetic Transcriptional Control Module to Drive Critical Leukemogenic Gene-Expression Programs

Fangxue Yan, Jinyang Li, Jelena Milosevic, Ricardo Petroni, Suying Liu, Zhennan Shi, Salina Yuan, Janice M. Reynaga, Yuwei Qi, Joshua Rico, Sixiang Yu, Yiman Liu, Susumu Rokudai, Neil Palmisiano, Sara E. Meyer, Pamela J. Sung, Liling Wan, Fei Lan, Benjamin A. Garcia, Ben Z. Stanger, David B. Sykes, M. Andres Blanco

Summary: The study identified histone acetyltransferase KAT6A as a key epigenetic regulator of AML cell differentiation. Mechanistically, KAT6A cooperates with ENL in an epigenetic transcriptional control module, revealing a new epigenetic dependency and therapeutic opportunity in AML.

CANCER DISCOVERY (2022)

Article Oncology

Epigenetic and Transcriptional Control of the Epidermal Growth Factor Receptor Regulates the Tumor Immune Microenvironment in Pancreatic Cancer

Jinyang Li, Salina Yuan, Robert J. Norgard, Fangxue Yan, Yu H. Sun, Il-Kyu Kim, Allyson J. Merrell, Yogev Sela, Yanqing Jiang, Natarajan Bhanu, Benjamin A. Garcia, Robert H. Vonderheide, Andres Blanco, Ben Z. Stanger

Summary: This study identifies lysine demethylase 3A (KDM3A) as an epigenetic regulator that affects the response to immunotherapy in pancreatic ductal adenocarcinoma by modulating the expression of epidermal growth factor receptor (EGFR) through Krueppel-like factor 5 (KLF5) and SMAD family member 4 (SMAD4). Inhibition of EGFR can reshape the immune microenvironment, offering a potential immunotherapy-sensitizing strategy for PDA.

CANCER DISCOVERY (2021)

Article Cell Biology

Overcoming Adaptive Resistance to KRAS and MEK Inhibitors by Co-targeting mTORC1/2 Complexes in Pancreatic Cancer

Wells S. Brown, Paul C. McDonald, Oksana Nemirovsky, Shannon Awrey, Shawn C. Chafe, David F. Schaeffer, Jinyang Li, Daniel J. Renouf, Ben Z. Stanger, Shoukat Dedhar

CELL REPORTS MEDICINE (2020)

No Data Available